Literature DB >> 4212424

The inhibition by somatostatin of the thyrotropin response to thyrotropin-releasing hormone in normal subjects.

J Weeke, A P Hansen, K Lundbaek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4212424

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


× No keyword cloud information.
  5 in total

1.  Dynamics of calcium-induced insulin release.

Authors:  G Devis; G Somers; W J Malaisse
Journal:  Diabetologia       Date:  1977-09       Impact factor: 10.122

2.  Combined pituitary stimulation test: interactions of hypothalamic releasing hormones in man.

Authors:  R W Holl; U Loos; W D Hetzel; E Heinze; H L Fehm
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

3.  Growth hormone release inhibiting hormone: actions on thyrotrophin and prolactin secretion after thyrotrophinreleasing hormone.

Authors:  D Carr; A Gomez-Pan; D R Weightman; V C Roy; R Hall; G M Besser; M O Thorner; A S McNeilly; A V Schally; A J Kastin; D H Coy
Journal:  Br Med J       Date:  1975-07-12

4.  Effect of somatostatin on thyrotropin, prolactin, growth hormone and insulin responses to thyrotropin releasing hormone and arginine in healthy, hypothyroid and acromegalic subjects.

Authors:  N Faure; J H Dussault; A Nadeau; F Szots; H Guyda; F Labrie
Journal:  Can Med Assoc J       Date:  1977-09-03       Impact factor: 8.262

5.  Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects.

Authors:  V Schusdziarra; D Grube; H Seifert; J Galle; H Etzrodt; W Beischer; O Haferkamp; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1983-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.